Predicting Functional Recovery in Acute Heart Disease Using a Single Snapshot We Have a Winner⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. by Friedrich, Matthias G.
Journal of the American College of Cardiology Vol. 61, No. 1, 2013
© 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.10.009EDITORIAL COMMENT
Predicting Functional Recovery
in Acute Heart Disease
Using a Single Snapshot
We Have a Winner*
Matthias G. Friedrich, MD
Montreal, Quebec, Canada
Prediction is very difficult, especially about the future.
—Niels Bohr (1885–1962) (1)
Any diagnostic exam is a snapshot in time and thus cannot
easily predict dynamic processes without additional context.
This is often given by the known clinical course of a disease;
thus, based on their knowledge and experience, clinicians
combine their clinical assessment with the results of a
diagnostic test to make a therapeutic decision.
See page 54
Recent-onset dilated cardiomyopathy, generally repre-
senting an inflammatory response to viral infection, is an
example of a dynamic disease, because it is characterized by
acute regional and/or global inflammation with hyperemia,
edema, cell death, and dysfunction, which may or may not
recover. The reversibility of tissue pathology and associated
dysfunction is not only determined by the severity of the
initial inflammatory response, but is also subject to mechan-
ical stress caused by increased filling pressures, with subse-
quently high regional or global wall stress. The immune
response can vary dramatically between individuals and
depend on the general immune status of the patient and the
specific immune reaction to the specific trigger. Impor-
tantly, these processes are local in nature and thus, especially
in internal organs, are not amenable to a diagnosis through
a physical exam or even systemic markers such as blood
tests. Thus, a diagnostic test ideally also provides informa-
tion on function, mechanical stress (especially because filling
pressures can to some extent be modified by pharmacolog-
ical interventions), and tissue pathology. This explains the
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In this issue of the Journal, Kubanek et al. (2) report a
study using cardiovascular magnetic resonance (CMR),
known cardiac serum biomarkers, and endomyocardial bi-
opsy to predict left ventricular reverse remodeling in pa-
tients with recent-onset dilated cardiomyopathy. When
comparing the predictive value of these markers for left
ventricular recovery, they found that a smaller extent of
irreversible injury (as measured in late gadolinium enhance-
ment images) and myocardial edema, both acquired at
baseline, were the strongest independent predictors,
whereas after 3 months, the latest brain natriuretic peptide
(BNP) was the only independent predictor. The authors
conclude that CMR and serial BNP are the most accurate
predictors for left ventricular reverse remodeling in recent-
onset dilated cardiomyopathy.
The paper has some limitations: The sample size is
limited, with only 15 patients considered as having inflam-
mation. Patient selection was based on the presence of left
ventricular dilation, and thus may have missed patients with
slowly evolving left ventricular dilation. The sample may
only represent a subgroup of patients with subacute or
chronic disease. The clinical onset of disease was beyond the
time expected for acute myocarditis, also suggested by the
observation that left ventricular size did not differ between
inflammatory and idiopathic patients and by the lack of a
difference with regard to markers of acute disease (high-
sensitivity troponin T, viral genome presence, BNP, and
C-reactive protein) between inflammatory and idiopathic
cardiomyopathy as defined by biopsy. Therefore, the results
may only be applicable in patients with suspected chronic
inflammation as defined by biopsy.
Biopsy, used as a gold standard, was obtained from the
right ventricular septum, a location that is known to be a
rather infrequent site of inflammation-induced injury and
even less so in patients with parvovirus B19 (3), the virus
reported in 25 of the patients of this study. Therefore, the
value of biopsy to serve as a standard of truth is unclear.
Furthermore, the authors did not match the location of
CMR findings of irreversible injury with biopsy. Finally, the
paper does not well reflect a clinical “real-life” scenario,
since a reader would not look at the results of edema and
scar separately, but take both into account. Thus, the
combined use of these criteria may have further improved
the predictive value of CMR.
Yet, despite these shortcomings, the paper provides
important comparative data on the predictive value of
various markers acquired at different time points. The work
underscores the value of CMR as a uniquely comprehensive
tool for diagnosing myocardial disease, which not only
provides a precise snapshot of the current status, but also
delivers several strong predictive markers.
Regional myocardial edema as assessed by edema-
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is especially impressive in stress-induced cardiomyopathy,
where the recovery of an extensive wall motion abnormality
can be predicted by the presence of edema in the absence of
regionally matching irreversible injury (4).
Regional persistence of gadolinium as the key interstitial
MR contrast agent as demonstrated by scar-sensitive CMR
(“late gadolinium enhancement”) indicates irreversible in-
jury and thus is associated with a lack of functional recovery,
acting as a predictor for a lack of functional recovery in acute
myocardial inflammation. Of note, this finding has also
been proven as a strong predictor of mortality (5).
The diagnostic and prognostic value of global left ven-
tricular dysfunction, typically reported as ejection fraction,
has been demonstrated. Furthermore, the presence of re-
gional wall motion abnormalities has a strong predictive
value even in the general population (6).
It is important to keep in mind that all these markers can
be easily assessed during 1 scan of 25 min.
There is little doubt that in patients with recent-onset
cardiomyopathy, as in other acute myocardial diseases,
functional recovery can generally be predicted by a single
CMR scan if done at the time of clinical presentation.
Clinical trials using standardized protocols in larger samples
are warranted. If these results can be confirmed, the predic- ytion of the future, at least in acute myocardial disease, may
not be that difficult after all.
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